MedPath

Ketamine- Propofol Versus Pethidine- Propofol in ERCP

Phase 2
Completed
Conditions
Sedation in ERCP
Interventions
Registration Number
NCT02651792
Lead Sponsor
Assiut University
Brief Summary

The investigators aim to investigate the differences between ketamine propofol and pethidine propofol during ERCP in respect to endoscopist satisfaction.

Detailed Description

The investigators aim to investigate the differences between ketamine propofol and pethidine propofol during ERCP in respect to endoscopist satisfaction, amount of propofol consumption Any desaturation or apnea will be recorded when the oxygen saturation (SpO2) dropped to \<90% , time for recovery ,post-operative nausea and vomiting, hallucinations and Ramsey sedation scores of all patients will be recorded perioperatively. The Aldrete score was used to measure recovery from anesthesia at 5 and 10 min after the procedure.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • both gender
  • age between 18-70
Exclusion Criteria
  • pregnant patients.
  • morbid obesity.
  • chronic obstructive pulmonary disease.
  • complicated airway.
  • American society of anesthesia (ASA) physical classification IV-V.
  • history of allergy or contraindications to the drugs used in the study
  • emergency need for ERCP.
  • those whose informed consent could not be signed.
  • those with possible complex ERCP.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ketamine- propofolketamine- propofolIV Ketamine 1mg/kg + Propofol 1.2 mg/kg will be given for sedation.
pethidine- propofolpethidine- propofol1.1 mg x kg(-1) pethidine + 1.2 mg x kg(-1) propofol for sedation induction
Primary Outcome Measures
NameTimeMethod
endoscopist satisfaction using 5 step scale (5= optimal condition; 1= poor condition)Immediately after procedure.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Al Rajhy liver hospital

🇪🇬

Asyut, Egypt

© Copyright 2025. All Rights Reserved by MedPath